University of Washington Health Sciences Research Studies Seeking Volunteers

13 item(s) returned.
To access detailed information about a study, click on the study #.

Specific Diseases or Conditions
Study #	Title
06-4019-A01	A Phase II, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment (ACTG 5235) Short Title: Minocycline for HIV-Associated Dementia
35676	A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers (ACTG 5257)
35676 B	A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers (ACTG 5257)
064331D	A Randomized, Open-Label, Crossover Trial of the Effect of Dosing of Daily HSV-2 Suppressive Therapy on HSV Reactivation and Plasma and Genital HIV-1 Levels Among HIV-1/HSV-2 co-Infected Persons
041776B04	Bronchoalveolar Lavage-Collected Alveolar Macrophages as a Reservoir for HIV
950369AC	Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply Exposed Seronegative Individuals
4325	Evaluation of HIV-Specific Immunological and Virological Responses of HIV-1 Multiply-Exposed Seronegative Individuals – Low Risk Controls
33717	Evaluation of Therapy with Zostavax® for HIV-1-Infected Adults on ART with Conserved Immune Function. (ACTG STUDY 5247)
975913A	Immune Determinants Favoring Non-Progression in HIV-1 Infection
33548	IMMUNOGENICITY & SAFETY OF AN HPV VACCINE IN HIV-POSITIVE WOMEN (ACTG 5240)
34908	Impact of Raltegravir (Isentress)-Containing Regimens on HIV-1 Infected CD4+T-Cells During Acute and Early HIV-1 Infection: A Randomized, Controlled Study Comparing Standard Anitretroviral Therapy to Standard Therapy Plus Raltegravir
4952	Screening for Volunteers to Particpate in HIV Vaccine Trials at the Fred Hutchinson Cancer Research Center/University of Washington Vaccine Trials Unit
33254	The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen. (ACTG 5241)